📰 2 sources covering this story

STAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more

First covered 20 hrs ago · latest take 14 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

STAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more
STAT News
STAT News14 mins ago
STAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more
The discovery that a fugitive had been working under an alias in the biotech industry prompted a question: How did he evade scrutiny for two decades?
Fox News
Fox News🏁 first to report20 hrs ago
Millions could gain easier access to popular peptides after FDA panel vote
An FDA panel voted to recommend six peptides including BPC-157, TB-500, and KPV for compounding by licensed pharmacies instead of grey market vendors.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →